Bayer AG - Annual Report 2006

#keyvisual { height: 19.1875em; }

Special Interest

Investor Relations

Press

Jobs and Career

Culture

General Conditions of Use Privacy Statement Imprint Technical Details

Cover picture

Invigorating drug discovery

Following Bayer’s successful acquisition of Schering AG, Berlin, Germany, the two companies’ researchers have joined forces in the search for new drugs. The picture shows two Bayer Schering Pharma AG, Germany* scientists – Dr. Ulrike Fuhrmann, formerly of Schering, and Dr. Thomas Krämer, formerly of Bayer Pharmaceuticals – meeting for an exchange of views. In the background is a laboratory at the research center in Wuppertal, Germany.

The names "Bayer Schering Pharma" or "Schering" as used in this publication always refer to Bayer Schering Pharma AG, Berlin, Germany, or its predecessor, Schering AG, Berlin, Germany, respectively.